drugset / Trial / NCT03525912

Neuropsychiatric and Cardiovascular Side Effects in Ketamine Analgesic Infusions

NCT03525912 ↗

Completed 101 enrolled Universidad de Antioquia
NaSingle-groupOpen-labelTreatment

Summary

Evaluation of neuropsychiatric and cardiovascular side effects of low dose ketamine analgesic infusion for postoperative pain

Timeline

Start
2017-07-01
Primary completion
2018-03-31
Completion
2018-11-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.1 mg/kg —

Indications